Women's health startups using AI are pulling further ahead on valuation, mirroring the broader VC market, per SVB data.
Driving the news: Flagship Pioneering's ProFound Therapeutics last week secured up to $35 million from the Gates Foundation to use its AI-enabled discovery platform for preeclampsia and eclampsia.
